MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$90,850K
Accounts receivable, net
$23,357K
Prepaid expenses and
other current assets
$8,527K
Inventory
$3,599K
Total current assets
$126,333K
Operating lease
right-of-use assets
$4,409K
Restricted cash
$317K
Other assets
$267K
Property and equipment,
net
$91K
Total assets
$131,417K
Accumulated deficit
-$1,781,891K
Total liabilities and
stockholders' deficit
$131,417K
Total stockholders'
deficit
-$265,646K
Additional paid-in capital
$1,516,188K
Accumulated other
comprehensive income
$43K
Common stock, 0.0001
par value 106,000...
$14K
Total liabilities
$397,063K
Total current
liabilities
$117,302K
Senior secured term
loan, net of current...
$88,245K
Convertible senior notes due
2029
$86,252K
Deferred royalty
obligation
$72,338K
Convertible senior notes due
2028
$17,659K
Common stock warrants
$9,521K
Operating lease
liabilities, net of current...
$5,468K
Other liabilities
$278K
Accrued expenses
$76,303K
Senior secured term
loan
$32,232K
Accounts payable
$4,279K
Other current
liabilities
$3,470K
Operating lease
liabilities
$1,018K
Back
Back
Balance Sheet
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)
source: myfinsight.com